 Intellect Design Arena Ltd consolidated Q2FY26 net profit up at Rs. 102.27 crores
Intellect Design Arena Ltd consolidated Q2FY26 net profit up at Rs. 102.27 crores Emkay Global Financial Services Ltd consolidated Q2 FY2026 PAT slumps to Rs. 45.95 lakhs
Emkay Global Financial Services Ltd consolidated Q2 FY2026 PAT slumps to Rs. 45.95 lakhs Dhanuka Agritech Ltd Q2 FY2026 PAT at Rs. 93.96 crores
Dhanuka Agritech Ltd Q2 FY2026 PAT at Rs. 93.96 crores Divyashakti Ltd Q2 FY26 loss at Rs. 8.34 lakhs
Divyashakti Ltd Q2 FY26 loss at Rs. 8.34 lakhs Mphasis Ltd Q2FY26 consolidated net profit up at Rs. 469.07 crores
Mphasis Ltd Q2FY26 consolidated net profit up at Rs. 469.07 crores 
              A meeting of the Board of Directors of Celestial Biolabs Ltd will be held on March 22, 2014, to consider the proposal to allot 15,00,000 Equity shares on preferential basis to promoter group and non promoter group.
The Board will also consider proposal to allot the third tranche of sweat equity shares comprising of 12,50,000 equity shares to Dr. A. N. Singh, Chairman and Managing Director of the Company subject to approvals from the statutory bodies.
Shares of Celestial Biolabs Limited was last trading in BSE at Rs.20.15 as compared to the previous close of Rs. 19.8. The total number of shares traded during the day was 35621 in over 402 trades.
The stock hit an intraday high of Rs. 20.55 and intraday low of 19.6. The net turnover during the day was Rs. 716563.